Clinical Research from Clinical Investigation Services

Call Today to Qualify

262-925-1280

Open Hours

Monday – Friday 8 am to 5pm

Have you been diagnosed with Psoriatic Arthritis?

Trial Information:

The INSPIRE 1 trial by SunPharma will test how effective, safe and tolerable the study drug, tildrakizumab, is compared to placebo in the treatment of psoriatic arthritis. Tildrakizumab is an antibody being tested or used for different conditions such as psoriatic arthritis.These are conditions related to how your immune system is functioning. An antibody is a protein made by the body’s immune (defense) system to fight infection by binding other proteins and molecules.

This trial is running at three of our affiliate research sites:

  • Orland Park, IL (Dr. Cory Conniff)
  • Schaumburg, IL (Dr. Kamran Chaudhary)
  • Skokie, IL (Dr. Robert Hozman)

We are currently accepting new patients for this study.

For more information on this clinical trial, please call us at 847-691-3856 and ask to speak to our recruiter Maria.

Study Protocol: TILD-19-07

Title
When Should We Contact You?
When would it be best for a member of our team to contact you? Please select all that apply.
How Did You Hear About Us?
How did you hear about Clinical Investigation Specialists? Please select all that apply.
If you heard about CIS from someone, please let us know! This field is not required. 
CIS Research is a robust, multi-site network of clinical trial sites. This means we are always running many types of research studies. We would like to contact you if there is a trial that you may be a qualified candidate for in the future. Please tell us a little bit about the types of trials you are interested in.
Please provide any other information you think we should know before a member of our team contacts you.

Dr. Eva Agaiby

President, Director of Clinical Trials & Regulatory Affairs

View Profile

Allen Banoub, MBA

Director of Marketing & Business Development

View Profile